Table 1.
Demographic and baseline clinical characteristics of the study series.
| e13a2 (n = 76) |
e14a2 (n = 126) |
Total (n = 202) |
p Value | ||
|---|---|---|---|---|---|
| Sex (male/total) (%) | 37/76 (49) | 67/127 (53) | 104/202 (52) | 0.536 | |
| Age, median (min, max) | 54 (15, 83) | 57 (12, 84) | 56 (12, 84) | 0.828 | |
| Splenomegaly, n (%) Median cm (min, max) |
23/75 (31) 4 (2, 20) |
39/120 (33) 5 (1, 30) |
62/195 (32) 5 (1, 30) |
0.789 0.542 |
|
| Platelets (x10e9/L), median (min, max) | 314 (37, 2236) | 386 (21, 1872) | 364 (21, 2236) | 0.241 | |
| Blasts PB (%), median (min, max) | 0 (0, 11) | 0 (0, 11) | 0 (0, 11) | 0.918 | |
| Cytogenetics, n (%) | t(9;22) | 61/68 (90) | 99/116 (85) | 160/184 (87) | 0.397 |
| t(9;22) + others | 7/68 (10) | 17/116 (15) | 24/184 (13) | ||
| EUTOS, median (min, max) | 28 (0, 143) | 28 (0, 148) | 28 (0, 148) | 0.358 | |
| EUTOS > 87, n (%) | 3/75 (4) | 13/120 (11) | 16/195 (8) | 0.091 | |
| Sokal, n (%) | Low risk | 39/75 (52) | 46/120 (38) | 85/195 (44) | 0.173 |
| Int risk | 26/75 (35) | 54/120 (45) | 80/195 (41) | ||
| High risk | 10/75 (13) | 20/120 (17) | 30/195 (15) | ||
| ELTS, n (%) | Low risk | 43/75 (57) | 61/120 (51) | 104/195 (53) | 0.376 |
| Int/High risk | 32/75 (43) | 59/120 (49) | 91/195 (47) | ||
PB: peripheral blood; ELTS: EUTOS long-term survival score; Int: intermediate.